The megabillion-dollar buyout of Life Technologies (NASDAQ: LIFE ) by Thermo Fisher Scientific (NYSE: TMO ) grabbed a lot of headlines earlier this week. Fool contributor Rich Smith, however, has a different story to tell.
It's the story of one overpriced company buying another company that's an even worse bargain, which resulted in a medical equipment behemoth that's even more egregiously overpriced than the two companies were separately.
Want a better health-care investing idea? When President Obama was reelected, shares of UnitedHealth and other health insurers fell immediately. Is Obamacare a death knell for health insurers, or is the market missing out on some of the opportunities the law presents? In this brand-new premium report on UnitedHealth, The Motley Fool takes a long-term view, honing in on prospects for UnitedHealth in a post-Obamacare world. So don't miss out -- simply click here now to claim your copy today.